tiprankstipranks
Trending News
More News >
Sol-Gel Technologies (SLGL)
NASDAQ:SLGL
Advertisement

Sol-Gel Technologies (SLGL) Price & Analysis

Compare
398 Followers

SLGL Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

0.48%17.71%99.52%
Insiders
17.71% Other Institutional Investors
99.52% Public Companies and
Individual Investors

SLGL FAQ

What was Sol-Gel Technologies’s price range in the past 12 months?
Sol-Gel Technologies lowest stock price was $3.35 and its highest was $16.50 in the past 12 months.
    What is Sol-Gel Technologies’s market cap?
    Sol-Gel Technologies’s market cap is $30.64M.
      When is Sol-Gel Technologies’s upcoming earnings report date?
      Sol-Gel Technologies’s upcoming earnings report date is Aug 07, 2025 which is in 9 days.
        How were Sol-Gel Technologies’s earnings last quarter?
        Sol-Gel Technologies released its earnings results on May 23, 2025. The company reported -$3.2 earnings per share for the quarter, missing the consensus estimate of -$1.246 by -$1.954.
          Is Sol-Gel Technologies overvalued?
          According to Wall Street analysts Sol-Gel Technologies’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Sol-Gel Technologies pay dividends?
            Sol-Gel Technologies does not currently pay dividends.
            What is Sol-Gel Technologies’s EPS estimate?
            Sol-Gel Technologies’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Sol-Gel Technologies have?
            Sol-Gel Technologies has 2,785,762 shares outstanding.
              What happened to Sol-Gel Technologies’s price movement after its last earnings report?
              Sol-Gel Technologies reported an EPS of -$3.2 in its last earnings report, missing expectations of -$1.246. Following the earnings report the stock price went down -1.172%.
                Which hedge fund is a major shareholder of Sol-Gel Technologies?
                Currently, no hedge funds are holding shares in SLGL

                Sol-Gel Technologies Stock Smart Score

                Company Description

                Sol-Gel Technologies

                Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has completed Phase III clinical trials for the treatment of acne vulgaris; Epsolay, a once-daily topical cream that has completed Phase III clinical trials for the treatment of papulopustular rosacea; SGT-210, which is in Phase I clinical trial for the treatment of palmoplantar keratoderma; and Erlotinib, Tapinarof, and roflumilast to treat psoriasis and other medical conditions. It is also involved in the development of generic topical dermatological drug products. The company has collaboration with Perrigo. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
                Similar Stocks
                Company
                Price & Change
                Follow
                Curis
                Cellectar Biosciences
                Cocrystal Pharma
                Capstone Therapeutics
                BiomX
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis